Quantbot Technologies LP Kala Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $7,503 - $22,632	-12,300 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.74 $13,356 - $31,548	11,514 Added 1464.89%	12,300 $14,000
Q3 2021 Nov 09, 2021	SELL	$2.62 - $5.43 $12,767 - $26,460	-4,873 Reduced 86.11%	786 $2,000
Q2 2021 Aug 12, 2021	BUY	$5.06 - $8.15 $28,634 - $46,120	5,659 New	5,659 $29,000
Q1 2021 May 14, 2021	SELL	$6.24 - $9.58 $15,487 - $23,777	-2,482 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.28 - $8.79 $11,197 - $15,672	1,783 Added 255.08%	2,482 $16,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $27,952 - $41,406	-3,727 Reduced 84.21%	699 $5,000
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $36,868 - $61,034	4,426 New	4,426 $46,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.1M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.